Esperion Therapeutics, Inc. (ESPR)

2.72 -0.05 (-1.81%) USD  |  NASDAQ  |  Mar 06, 16:00
2.725 0.00 (0.00%) After-Hours: 20:00
More

Esperion Therapeutics Domestic Sales (5 Year Growth)

Domestic Sales (5 Year Growth) Chart

View Domestic Sales (5 Year Growth) for ESPR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Domestic Sales (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Domestic Sales (5 Year Growth) Range, Past 5 Years

View Domestic Sales (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Domestic Sales (5 Year Growth) Benchmarks

View Domestic Sales (5 Year Growth) Benchmarks
Start Trial
Harrow, Inc. --
Catalyst Pharmaceuticals, Inc. --
Nektar Therapeutics --
Rigel Pharmaceuticals, Inc. --
AnaptysBio, Inc. --